These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26056328)

  • 21. Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy.
    Kanai K; Kikuchi E; Ohigashi T; Miyajima A; Nakagawa K; Nakashima J; Oya M
    Int J Clin Oncol; 2008 Dec; 13(6):510-4. PubMed ID: 19093178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC.
    Lee Y; Kim YS; Hong B; Cho YM; Lee JL
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3421-3429. PubMed ID: 33715088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
    Song Y; Yang L; Zhou A; Chi Y; Wang J
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):212-6. PubMed ID: 24785283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer.
    Roberts JT; von der Maase H; Sengeløv L; Conte PF; Dogliotti L; Oliver T; Moore MJ; Zimmermann A; Arning M
    Ann Oncol; 2006 May; 17 Suppl 5():v118-22. PubMed ID: 16807438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.
    Bellmunt J; Guillem V; Paz-Ares L; González-Larriba JL; Carles J; Albanell J; Tabernero JM; Cortés-Funes H; Baselga J
    Eur J Cancer; 2000 Jul; 36 Suppl 2():17-25. PubMed ID: 10908844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.
    De Santis M; Bellmunt J; Mead G; Kerst JM; Leahy M; Maroto P; Gil T; Marreaud S; Daugaard G; Skoneczna I; Collette S; Lorent J; de Wit R; Sylvester R
    J Clin Oncol; 2012 Jan; 30(2):191-9. PubMed ID: 22162575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of metastatic bladder cancer].
    Gauthier H; Serrate C; Pouessel D; Le Maignan C; Teixeira L; Culine S
    Rev Prat; 2014 Dec; 64(10):1405-7. PubMed ID: 25668832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Active chemotherapy with gemcitabine, carboplatin and docetaxel for three patients with MVAC-resistant liver metastasis of urothelial carcinoma].
    Inoue T; Ohyama C; Horikawa Y; Togashi H; Matsuura S; Tsuchiya N; Satoh S; Sato K; Habuchi T; Saito S; Hoshi S; Arai Y; Kato T
    Hinyokika Kiyo; 2004 Apr; 50(4):273-7. PubMed ID: 15188623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.
    Park JH; Lee SW; Kim HS; Kang SG; Ko YH; Kim ST; Kang SH; Park YJ; Choi IK; Oh SC; Sung DJ; Seo JH; Cheon J; Kim YH; Kim JS; Park KH
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):1033-9. PubMed ID: 23370665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].
    Lehmann J; Retz M; Steiner G; Albers P; Jaeger E; Knuth A; Lippert C; Koser M; Stockamp K; Otto C; Melchior H; Fassmann C; Potratz C; Loch T; Derigs HG; Becker T; Kälble T; Piechota HJ; Hertle L; Weinknecht S; Weissbach L; Al-Mwalad M; Hamza A; Henss H; Brkovic D; Pomer S; Roloff J; Walz P; Muschter R; Tunn U; Winter E; Bub P; Kaldenbach U; Roth S; Brauers A; Jakse G; Richter AE; Wirth M; Hartlapp J; Van Ahlen H; Stöckle M
    Urologe A; 2003 Aug; 42(8):1074-86. PubMed ID: 14513232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel gemcitabine-containing triplets in the management of urothelial cancer.
    Hussain M; Vaishampayan U; Smith DC
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):20-4. PubMed ID: 11894004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium.
    Bellmunt J; Albiol S; de Olano AR; Pujadas J; Maroto P;
    Ann Oncol; 2006 May; 17 Suppl 5():v113-7. PubMed ID: 16807437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.
    Hussain SA; Stocken DD; Riley P; Palmer DH; Peake DR; Geh JI; Spooner D; James ND
    Br J Cancer; 2004 Aug; 91(5):844-9. PubMed ID: 15292922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.
    Galsky MD; Iasonos A; Mironov S; Scattergood J; Boyle MG; Bajorin DF
    Cancer; 2007 Feb; 109(3):549-55. PubMed ID: 17200962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy.
    Sun P; Xue C; Li LR; Shao C; An X; Thomas R; Yang W; Deng YF; Jiang WQ; Shi YX
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):37-44. PubMed ID: 28534209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature.
    Oing C; Rink M; Oechsle K; Seidel C; von Amsberg G; Bokemeyer C
    J Urol; 2016 Feb; 195(2):254-63. PubMed ID: 26410730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study).
    Matsui Y; Ogawa O; Ishitsuka R; Miyazaki J; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Fujie K; Keino N; Nishiyama H
    Int J Clin Oncol; 2016 Dec; 21(6):1142-1149. PubMed ID: 27349431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma.
    Hosogoe S; Hatakeyama S; Kusaka A; Hamano I; Iwamura H; Fujita N; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ohyama C
    Eur Urol Focus; 2018 Dec; 4(6):946-953. PubMed ID: 28753881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.
    Birtle A; Johnson M; Chester J; Jones R; Dolling D; Bryan RT; Harris C; Winterbottom A; Blacker A; Catto JWF; Chakraborti P; Donovan JL; Elliott PA; French A; Jagdev S; Jenkins B; Keeley FX; Kockelbergh R; Powles T; Wagstaff J; Wilson C; Todd R; Lewis R; Hall E
    Lancet; 2020 Apr; 395(10232):1268-1277. PubMed ID: 32145825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.
    Adamo V; Magno C; Spitaleri G; Garipoli C; Maisano C; Alafaci E; Adamo B; Rossello R; Scandurra G; Scimone A
    Oncology; 2005; 69(5):391-8. PubMed ID: 16319510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.